Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped ...
Of the 84 patients aged 21 or younger who were diagnosed with colorectal cancer at participating hospitals between 2012 and ...
March is Colorectal Cancer Awareness Month. Physicians at Gastro of the Rockies urge Colorado residents not to overlook growing trend in early onset cancer. Colon cancer in the past was thought to be ...
The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...
The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for ...
New research presented at the American Academy of Pediatrics conference has found that colorectal cancer is becoming ...
The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...